Supplementary Figure 1 from Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor
Year: 2023
Type: supplementary-materials
Abstract: Flow cytometric analyses depicting the percentage of splenocytes from mice that express CD4 or CD8 indicating the two T cell subsets.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362532314